Drug
N-Acetylcystein
N-Acetylcystein is a pharmaceutical drug with 5 clinical trials. Historical success rate of 75.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(20%)
Phase Distribution
Ph phase_3
1
20%
Ph phase_2
2
40%
Ph phase_4
2
40%
Phase Distribution
0
Early Stage
2
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
2(40.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Terminated(1)
Other(1)
Detailed Status
Completed3
unknown1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
75.0%
Most Advanced
Phase 4
Trials by Phase
Phase 22 (40.0%)
Phase 31 (20.0%)
Phase 42 (40.0%)
Trials by Status
completed360%
unknown120%
terminated120%
Recent Activity
0 active trials
Showing 5 of 5
terminatedphase_2
Clinical Trial of N-acetylcysteine Versus Placebo Efficacy in the Cannabis Withdrawal
NCT01439828
completedphase_4
Neurobiological Adaptations and Pharmacological Interventions in Cocaine Addiction
NCT02626494
completedphase_2
Use of N-Acetylcysteine During Liver Procurement
NCT01394497
unknownphase_3
Effect of N-acetylcystein in Myocardial Infarction
NCT01741207
completedphase_4
NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization
NCT00356954
Clinical Trials (5)
Showing 5 of 5 trials
NCT01439828Phase 2
Clinical Trial of N-acetylcysteine Versus Placebo Efficacy in the Cannabis Withdrawal
NCT02626494Phase 4
Neurobiological Adaptations and Pharmacological Interventions in Cocaine Addiction
NCT01394497Phase 2
Use of N-Acetylcysteine During Liver Procurement
NCT01741207Phase 3
Effect of N-acetylcystein in Myocardial Infarction
NCT00356954Phase 4
NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5